Page last updated: 2024-11-08

triiodothyronine and Metabolically Benign Obesity

triiodothyronine has been researched along with Metabolically Benign Obesity in 1 studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jun, JE1
Kim, TH1
Lee, SE1
Lee, YB1
Jee, JH1
Bae, JC1
Jin, SM1
Hur, KY1
Kim, JH1
Kim, SW1
Chung, JH1
Min, YK1
Lee, MK1

Other Studies

1 other study available for triiodothyronine and Metabolically Benign Obesity

ArticleYear
Hormetic effect of triiodothyronine in metabolically healthy obese persons.
    Endocrine, 2017, Volume: 57, Issue:3

    Topics: Academic Medical Centers; Adiposity; Adult; Body Mass Index; Female; Hormesis; Humans; Incidence; In

2017